Back to results
US 9,603,939 B2Granted
Platform drug delivery system utilizing crystal engineering and theanine dissolution
AssigneeTheaprin Pharmaceuticals Inc.
InventorsHarry G. Brittain, Philip V. Felice
Life of this patent
Estimating the term…
Abstract
A method of treating Hodgkin's disease in a subject. The method involves administering to the subject an effective amount of a water-soluble composition which includes a cocrystal composition containing doxorubicin and a theanine enantiomer.
Claims3
A method of treating Hodgkin's disease in a subject comprising administering an effective amount of a water-soluble composition comprising:
- a cocrystal containing doxorubicin and L-theanine;
- wherein said cocrystal is characterized as having an X-ray powder diffraction pattern with peaks (2θ) at 13.6, 18.2, 19.8, 22.0, 22.5, 25, and 38.2 degrees.
Dependencies are inferred from the claim text.